Clin Colon Rectal Surg 2023; 36(06): 385-390
DOI: 10.1055/s-0043-1767707
Review Article

Update on Surgical Management of FAP

Tianqi Zhang
1   Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China
,
Ye Xu
1   Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China
› Author Affiliations

Abstract

Familial adenomatous polyposis (FAP) is an autosomal dominant disease caused by pathogenic germline adenomatous polyposis coli mutation, and characterized with multiple adenomas in the colon and the rectum. Various genetic variants have been confirmed to be associated with corresponding FAP phenotypes, which play important roles in the diagnosis and surgical treatment of FAP. Generally, proctocolectomy is recommended for FAP patients at the age of 20s. Exceptionally, for patients with attenuated FAP, high-risk of desmoid, chemoprevention therapy, or other circumstances, surgery can be postponed. With the wide application of minimal invasive surgery in colorectal cancer, laparoscopic, robotic surgery, and natural orifice specimen extraction are proved to be feasible for FAP patients, but high-level evidences are needed to confirm their safety and advantages. In the times of precise medicine, the surgical management of FAP should vary with individuals based on genotype, phenotype, and clinical practice. Therefore, in addition to innovation in surgical procedures, investigation in links between genetic features and phenotypes will be helpful to optimize the surgical management of FAP in the future.



Publication History

Article published online:
17 April 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Zeggini E, Gloyn AL, Barton AC, Wain LV. Translational genomics and precision medicine: moving from the lab to the clinic. Science 2019; 365 (6460): 1409-1413
  • 2 Rofes P, González S, Navarro M. et al. Paired somatic-germline testing of 15 polyposis and colorectal cancer-predisposing genes highlights the role of APC mosaicism in de novo familial adenomatous polyposis. J Mol Diagn 2021; 23 (11) 1452-1459
  • 3 Giang H, Nguyen VT, Nguyen SD. et al. Detection of a heterozygous germline APC mutation in a three-generation family with familial adenomatous polyposis using targeted massive parallel sequencing in Vietnam. BMC Med Genet 2018; 19 (01) 188
  • 4 Druliner BR, Ruan X, Sicotte H. et al. Early genetic aberrations in patients with sporadic colorectal cancer. Mol Carcinog 2018; 57 (01) 114-124
  • 5 Nieuwenhuis MH, Vasen HF. Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit Rev Oncol Hematol 2007; 61 (02) 153-161
  • 6 Tomita N, Ishida H, Tanakaya K. et al; Japanese Society for Cancer of the Colon, Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the clinical practice of hereditary colorectal cancer. Int J Clin Oncol 2021; 26 (08) 1353-1419
  • 7 Ophir G, Sivan S, Hana S. et al. Abdominal desmoid: course, severe outcomes, and unique genetic background in a large local series. Cancers (Basel) 2021; 13 (15) 3673
  • 8 Ashar S, Lipsa A, Khan N, Sarin R. High cumulative risk of colorectal cancers and desmoid tumours and fibromatosis in South Asian APC mutation carriers. J Med Genet 2022; 59 (05) 492-495
  • 9 Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW. American College of Gastroenterology. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 2015; 110 (02) 223-262 , quiz 263
  • 10 Weiss JM, Gupta S, Burke CA. et al. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021. J Natl Compr Canc Netw 2021; 19 (10) 1122-1132
  • 11 Aelvoet AS, Buttitta F, Ricciardiello L, Dekker E. Management of familial adenomatous polyposis and MUTYH-associated polyposis; new insights. Best Pract Res Clin Gastroenterol 2022; 58-59: 101793
  • 12 Mur P, García-Mulero S, Del Valle J. et al. Role of POLE and POLD1 in familial cancer. Genet Med 2020; 22 (12) 2089-2100
  • 13 Campos FG. Surgical treatment of familial adenomatous polyposis: dilemmas and current recommendations. World J Gastroenterol 2014; 20 (44) 16620-16629
  • 14 Talseth-Palmer BA. The genetic basis of colonic adenomatous polyposis syndromes. Hered Cancer Clin Pract 2017; 15: 5
  • 15 Fukushi G, Yamada M, Kaku Gawa Y. et al. Genotype-phenotype correlation of small intestinal polyps on small-bowel capsule endoscopy in familial adenomatous polyposis. Gastrointest Endosc 2023; 97 (01) 59-68.e7
  • 16 Leoz ML, Carballal S, Moreira L, Ocaña T, Balaguer F. The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management. Appl Clin Genet 2015; 8: 95-107
  • 17 Grover S, Kastrinos F, Steyerberg EW. et al. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. JAMA 2012; 308 (05) 485-492
  • 18 Disciglio V, Fasano C, Cariola F. et al. Gastric polyposis and desmoid tumours as a new familial adenomatous polyposis clinical variant associated with APC mutation at the extreme 3′-end. J Med Genet 2020; 57 (05) 356-360
  • 19 Scharf F, Leal Silva RM, Morak M. et al. Constitutional chromothripsis of the APC locus as a cause of genetic predisposition to colon cancer. J Med Genet 2022; 59 (10) 976-983
  • 20 Li N, Kang Q, Yang L. et al. Clinical characterization and mutation spectrum in patients with familial adenomatous polyposis in China. J Gastroenterol Hepatol 2019; 34 (09) 1497-1503
  • 21 Wang D, Liang S, Zhang X. et al. Targeted next-generation sequencing approach for molecular genetic diagnosis of hereditary colorectal cancer: Identification of a novel single nucleotide germline insertion in adenomatous polyposis coli gene causes familial adenomatous polyposis. Mol Genet Genomic Med 2019; 7 (01) e00505
  • 22 Wang D, Zhang Z, Li Y. et al. Adenomatous polyposis coli gene mutations in 22 Chinese pedigrees with familial adenomatous polyposis. Med Sci Monit 2019; 25: 3796-3803
  • 23 de Oliveira JC, Viana DV, Zanardo C. et al. Genotype-phenotype correlation in 99 familial adenomatous polyposis patients: a prospective prevention protocol. Cancer Med 2019; 8 (05) 2114-2122
  • 24 Khider F, Cherbal F, Boumehdi AL. et al. Germline mutations of the adenomatous polyposis coli (APC) gene in Algerian familial adenomatous polyposis cohort: first report. Mol Biol Rep 2022; 49 (05) 3823-3837
  • 25 Ge S, Cheng D, Zhang X. et al. Using genotype to assist clinical surveillance: a retrospective study of Chinese familial adenomatous polyposis patients. Am J Cancer Res 2022; 12 (09) 4254-4266
  • 26 Sarvepalli S, Burke CA, Monachese M. et al. Web-based model for predicting time to surgery in young patients with familial adenomatous polyposis: an internally validated study. Am J Gastroenterol 2018; 113 (12) 1881-1890
  • 27 Koskenvuo L, Ryynänen H, Lepistö A. Timing of prophylactic colectomy in familial adenomatous polyposis. Colorectal Dis 2020; 22 (11) 1553-1559
  • 28 Kobayashi H, Ishida H, Ueno H. et al. Association between the age and the development of colorectal cancer in patients with familial adenomatous polyposis: a multi-institutional study. Surg Today 2017; 47 (04) 470-475
  • 29 Anele CC, Martin I, McGinty Duggan PM. et al. Attenuated familial adenomatous polyposis: a phenotypic diagnosis but obsolete term?. Dis Colon Rectum 2022; 65 (04) 529-535
  • 30 Kemp Bohan PM, Mankaney G, Vreeland TJ. et al. Chemoprevention in familial adenomatous polyposis: past, present and future. Fam Cancer 2021; 20 (01) 23-33
  • 31 Cruz-Correa M, Hylind LM, Romans KE, Booker SV, Giardiello FM. Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology 2002; 122 (03) 641-645
  • 32 Solomon SD, McMurray JJ, Pfeffer MA. et al; Adenoma Prevention with Celecoxib (APC) Study Investigators. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005; 352 (11) 1071-1080
  • 33 West NJ, Clark SK, Phillips RK. et al. Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis. Gut 2010; 59 (07) 918-925
  • 34 Ng KS, Gonsalves SJ, Sagar PM. Ileal-anal pouches: a review of its history, indications, and complications. World J Gastroenterol 2019; 25 (31) 4320-4342
  • 35 Zhang Y, Hu H, Jiang C, Qian Q, Ding Z. D-pouch: a modified ileal J-pouch for patients with ulcerative colitis and familial adenomatous polyposis. Tech Coloproctol 2021; 25 (11) 1209-1215
  • 36 Konishi T, Ishida H, Ueno H. et al. Postoperative complications after stapled and hand-sewn ileal pouch-anal anastomosis for familial adenomatous polyposis: a multicenter study. Ann Gastroenterol Surg 2017; 1 (02) 143-149
  • 37 Qin T, Liao J, Qin H. et al. Advantages of total proctocolectomy with straight ileoanal anastomosis plus pedicled omental transposition for familial adenomatous polyposis: a preliminary study. World J Surg Oncol 2022; 20 (01) 20
  • 38 Wu XR, Ke HX, Kiran RP, Shen B, Lan P. Continent ileostomy as an alternative to end ileostomy. Gastroenterol Res Pract 2020; 2020: 9740980
  • 39 Shinji S, Yamada T, Matsuda A. et al. Recent advances in the treatment of colorectal cancer: a review. J Nippon Med Sch 2022; 89 (03) 246-254
  • 40 Hahn SJ, Sylla P. Technological advances in the surgical treatment of colorectal cancer. Surg Oncol Clin N Am 2022; 31 (02) 183-218
  • 41 Ahmed Ali U, Keus F, Heikens JT. et al. Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis. Cochrane Database Syst Rev 2009; (01) CD006267
  • 42 Ueno H, Kobayashi H, Konishi T. et al. Prevalence of laparoscopic surgical treatment and its clinical outcomes in patients with familial adenomatous polyposis in Japan. Int J Clin Oncol 2016; 21 (04) 713-722
  • 43 Konishi T, Ishida H, Ueno H. et al. Feasibility of laparoscopic total proctocolectomy with ileal pouch-anal anastomosis and total colectomy with ileorectal anastomosis for familial adenomatous polyposis: results of a nationwide multicenter study. Int J Clin Oncol 2016; 21 (05) 953-961
  • 44 Feng Q, Yuan W, Li T. et al; REAL Study Group. Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol 2022; 7 (11) 991-1004
  • 45 Park JS, Kang H, Park SY. et al. Long-term oncologic after robotic versus laparoscopic right colectomy: a prospective randomized study. Surg Endosc 2019; 33 (09) 2975-2981
  • 46 Degiuli M, Ortenzi M, Tomatis M. et al. Minimally invasive vs. open segmental resection of the splenic flexure for cancer: a nationwide study of the Italian Society of Surgical Oncology-Colorectal Cancer Network (SICO-CNN). Surg Endosc 2023; 37 (02) 977-988
  • 47 Protyniak B, Jorden J, Farmer R. Multiquadrant robotic colorectal surgery: the da Vinci Xi vs Si comparison. J Robot Surg 2018; 12 (01) 67-74
  • 48 Jimenez-Rodriguez RM, Quezada-Diaz F, Tchack M. et al. Use of the Xi robotic platform for total abdominal colectomy: a step forward in minimally invasive colorectal surgery. Surg Endosc 2019; 33 (03) 966-971
  • 49 Bianchi G, Gavriilidis P, Martínez-Pérez A. et al. Robotic multiquadrant colorectal procedures: a single-center experience and a systematic review of the literature. Front Surg 2022; 9: 991704
  • 50 Palanivelu C, Rangarajan M, Jategaonkar PA, Anand NV. An innovative technique for colorectal specimen retrieval: a new era of “natural orifice specimen extraction” (N.O.S.E). Dis Colon Rectum 2008; 51 (07) 1120-1124
  • 51 Zhang M, Liu Z, Wang X. Is natural orifice specimen extraction surgery the future direction of minimally invasive colorectal surgery?. Surg Open Sci 2022; 10: 106-110
  • 52 Awad Z. Laparoscopic total colectomy with transvaginal extraction of the colon and ileorectal anastomosis. Ann Surg Oncol 2014; 21 (09) 3029
  • 53 Kayaalp C, Yagci MA, Soyer V. Laparoscopic and natural orifice transluminal restorative proctocolectomy: no abdominal incision for specimen extraction or ileostomy. Wideochir Inne Tech Malo Inwazyjne 2016; 11 (02) 115-120
  • 54 Wolthuis AM, de Buck van Overstraeten A, D'Hoore A. Laparoscopic natural orifice specimen extraction-colectomy: a systematic review. World J Gastroenterol 2014; 20 (36) 12981-12992
  • 55 Vitellaro M, Sala P, Signoroni S. et al. Risk of desmoid tumours after open and laparoscopic colectomy in patients with familial adenomatous polyposis. Br J Surg 2014; 101 (05) 558-565
  • 56 Saito Y, Hinoi T, Ueno H. et al. Risk factors for the development of desmoid tumor after colectomy in patients with familial adenomatous polyposis: multicenter retrospective cohort study in Japan. Ann Surg Oncol 2016; 23 (Suppl. 04) 559-565